2 Pediatric Indications Sought for Golimumab
Longer Rituximab Therapy Boosts Remission in ANCA-Associated Vasculitis
Hydroxychloroquine Combination Risky for Cancer Patients with COVID-19
U.S. Insurers Often Limit Biosimilar Coverage
Long-Term Biologic Use May Not Raise Melanoma Risk
WHO Expects HCQ Safety Findings by Mid-June
Hydroxychloroquine Tied to Increased Risk of Death in COVID-19 Patients
U.K. Healthcare Workers Begin COVID-19 HCQ Trial
Rheumatology Biologic Expertise Valued for COVID-19 Treatment Decisions
- 1
- 2
- 3
- …
- 104
- Next Page »